Spinal myoclonus in subacute combined degeneration caused by nitrous oxide intoxication

Acta Neurologica Taiwanica

Volumn 16, Issue 2, 2007, Pages 102-105

  Wu, Mei Shian ^a,b   Hsu, Yaw Don ^a   Lin, Jiann Chyun ^a   Chen, Shih Cheng ^a,c   Lee, Jiunn Tay ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b Chung Shan Hospital   (Taiwan)

^c CHI MEI FOUNDATION HOSPITAL   (Taiwan)

Author keywords

Magnetic resonance imaging (MRI); Myoclonus; Nitrous oxide (N2O); Subacute combined degeneration (SCD); Vitamin B12

Indexed keywords

CYANOCOBALAMIN; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD CHEMISTRY; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; MYOCLONUS; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION;

ADULT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCLONUS; NITROUS OXIDE; SPINAL CORD DISEASES; SUBACUTE COMBINED DEGENERATION; VITAMIN B 12;

EID: 34447308496     PISSN: 10196099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. 2O cartridges through a whipped-cream dispenser. Neurology 1978;28:485-7.
2. Brett A. Myeloneuropathy from whipped cream bulbs presenting as conversion disorder. Aust N Z J Psychiatry 1997; 31:131-2.
3. Healton EB, Savage DG, Brust JC, et al. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 1991;70:229-45.
4. Metz J. Cobalamin deficiency and the pathogenesis of nervous system disease. Annu Rev Nutr 1992;12:59-79.
5. Green R, Kinsella LJ. Current concepts in the diagnosis of cobalamin deficiency. Neurology 1995;45:1435-40.
6. Blanco G, Peters HA. Myeloneuropathy and macrocytosis associated with nitrous oxide abuse. Arch Neurol 1983;40:416-8.
7. Marie RM, Le Biez E, Busson P, et al. Nitrous oxide anesthesia-associated myelopathy. Arch Neurol 2000;57:380-2.
8. Kinsella LJ, Green R. 'Anesthesia paresthetica': nitrous oxide-induced cobalamin deficiency. Neurology 1995;45:1608-10.
9. Ahn SC, Brown AW. Cobalamin deficiency and subacute combined degeneration after nitrous oxide anesthesia: a case report. Arch Phys Med Rehabil 2005;86:150-3.
10. Pema PJ, Horak HA, Wyatt RH. Myelopathy caused by nitrous oxide toxicity. AJNR Am J Neuroradiol 1998;19:894-6.
11. Shibasaki H. Electrophysiological studies of myoclonus. Muscle Nerve 2000;23:321-35.
12. Blindauer K. Myoclonus and its disorders. Neurol Clin 2001;19:723-34.
13. Brown P, Thompson PD, Rothwell JC, et al. Axial myoclonus of propriospinal origin. Brain 1991;114:197-214.
14. Grattan-Smith PJ, Wilcken B, Procopis PG, et al. The neurological syndrome of infantile cobalamin deficiency: developmental regression and involuntary movements. Mov Disord 1997;12:39-46.
15. Ozer EA, Turker M, Bakiler AR, et al. Involuntary movements in infantile cobalamin deficiency appearing after treatment. Pediatr Neurol 2001;25:81-3.
16. Celik M, Barkut IK, Oncel C, et al. Involuntary movements associated with vitamin B12 deficiency. Parkinsonism Relat Disord 2003;10:55-7.
17. Yagiela JA. Health hazards and nitrous oxide: a time for reappraisal. Anesth Prog 1991;38:1-11.
18. Louis-Ferdinand RT. Myelotoxic, neurotoxic and reproductive adverse effects of nitrous oxide. Adverse Drug React Toxicol Rev 1994;13:193-206.